CA ACR173

Designates the last Tuesday of every April as APOL1-Mediated Kidney Disease (AMKD) Awareness Day

Encourages individuals in the United States to become informed about kidney disease and AMKD, particularly people with ancestry from Western and Central Africa

Encourages genetic testing for apolipoprotein L1 (APOL1) gene mutations, which increase susceptibility to AMKD, a rapidly progressive form of kidney disease

Notes that an estimated 37 million Americans have kidney disease, with Black Americans disproportionately affected (35 percent of kidney failure cases despite comprising 13 percent of the population)

Highlights that 13 percent of Black Americans carry APOL1 gene variants in both copies, which creates a one in five chance of developing kidney disease